The current status of gene therapy

被引:0
作者
Clayman, GL [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Head & Neck Surg, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:39 / 43
页数:5
相关论文
共 19 条
[1]  
Alemany R, 1996, CANCER GENE THER, V3, P296
[2]   SUPPRESSION OF TUMORIGENICITY OF HUMAN PROSTATE CARCINOMA-CELLS BY REPLACING A MUTATED RB GENE [J].
BOOKSTEIN, R ;
SHEW, JY ;
CHEN, PL ;
SCULLY, P ;
LEE, WH .
SCIENCE, 1990, 247 (4943) :712-715
[3]  
Bouvet M, 1998, CANCER RES, V58, P2288
[4]  
BUTLER RE, 1998, CANCER GENE THER, V5, pS25
[5]   STABLE EXPRESSION OF THE WILD-TYPE P53 GENE IN HUMAN LUNG-CANCER CELLS AFTER RETROVIRUS-MEDIATED GENE-TRANSFER [J].
CAI, DW ;
MUKHOPADHYAY, T ;
LIU, YJ ;
FUJIWARA, T ;
ROTH, JA .
HUMAN GENE THERAPY, 1993, 4 (05) :617-624
[6]  
Clayman GL, 1999, CLIN CANCER RES, V5, P1715
[7]  
CLAYMAN GL, 1995, CANCER RES, V55, P1
[8]   Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma [J].
Clayman, GL ;
El-Naggar, AK ;
Lippman, SM ;
Henderson, YC ;
Frederick, M ;
Merritt, JA ;
Zumstein, LA ;
Timmons, TM ;
Liu, TJ ;
Ginsberg, L ;
Roth, JA ;
Hong, WK ;
Bruso, P ;
Goepfert, H .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2221-2232
[9]  
Clayman GL, 1997, CANC MED, P1645
[10]  
Frank DK, 1998, CLIN CANCER RES, V4, P2521